Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season

scientific article published on 17 March 2015

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIV177
P698PubMed publication ID25784728
P5875ResearchGate publication ID273784789

P50authorMel KrajdenQ6810759
Catharine ChambersQ57259188
Yan LiQ69032212
Nathalie BastienQ69032280
Hugues CharestQ86870110
Gaston De SerresQ86870133
Jonathan B GubbayQ87716515
Alireza EshaghiQ94927841
Danuta M. SkowronskiQ111259505
Suzana SabaiducQ114718265
Martin PetricQ114718266
Anne-Luise WinterQ114718267
Kevin FonsecaQ114718268
Paul Van CaeseeleQ114718272
Salaheddin M. MahmudQ42242293
James A DickinsonQ42422634
P2860cites workLive attenuated versus inactivated influenza vaccine in infants and young children.Q55043222
SWISS-MODEL: An automated protein homology-modeling serverQ24672647
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Q30360290
Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.Q30364076
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from CanadaQ30388012
A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strainsQ30396902
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.Q30399334
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisQ30408691
Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza virusesQ30419865
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?Q33990541
Serologic assays for influenza surveillance, diagnosis and vaccine evaluationQ34194336
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure historiesQ34332806
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza seasonQ34480810
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewQ34778408
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesQ35130915
Quantifying influenza vaccine efficacy and antigenic distance.Q35760689
Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccinesQ37208841
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.Q41474318
Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown virusesQ41516523
Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggsQ41884668
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.Q42237299
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccineQ42242172
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolutionQ42253862
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthmaQ44070675
Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.Q44243917
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variantsQ45167252
The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analysesQ45774432
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonQ47843797
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.Q48071872
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectinfluenza vaccineQ383260
P304page(s)726-739
P577publication date2015-03-17
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleIntegrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season
P478volume212